Coupang Investing Cash Flow increased by 19.7% to -$302.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 41.8%, from -$213.00M to -$302.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 16.7% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$155.10M | -$201.23M | -$169.19M | -$249.03M | -$180.67M | -$288.76M | -$129.55M | -$83.00M | -$429.00M | -$152.00M | -$263.00M | -$117.00M | -$178.00M | -$383.00M | -$141.00M | -$213.00M | -$299.00M | -$366.00M | -$376.00M | -$302.00M |
| QoQ Change | — | -29.7% | +15.9% | -47.2% | +27.4% | -59.8% | +55.1% | +35.9% | -416.9% | +64.6% | -73.0% | +55.5% | -52.1% | -115.2% | +63.2% | -51.1% | -40.4% | -22.4% | -2.7% | +19.7% |
| YoY Change | — | — | — | — | -16.5% | -43.5% | +23.4% | +66.7% | -137.4% | +47.4% | -103.0% | -41.0% | +58.5% | -152.0% | +46.4% | -82.1% | -68.0% | +4.4% | -166.7% | -41.8% |